Part 1: Shedding light on PCD- Introduction

Patient Experience Week honors the profound daily impact healthcare professionals have on the patient experience. As this year's commemoration begins, we're proud to introduce you to Bill Anton, Chairman of the PCD Foundation and a patient advocate living with Primary Ciliary Dyskinesia (PCD). Earlier this month, we spent a couple days with Billy learning about the day-to-day management of his PCD, his current symptoms and treatments, and his future outlook.

At ‪@ReCodeTx‬ we are committed to transforming the treatment landscape for genetic diseases like PCD. Through our research, including our PCD-focused mRNA-based therapy, RCT1100, designed to restore ciliary function by targeting the disease's root cause.